Current Partnering
Best Practice for Dealmakers
Home
Reports
Expert reports
Deal type reports
Deal review reports
Technology reports
Therapy reports
Company reports
Dealdocs
Dealdocs: Partnering
Dealdocs: M&A
Marketplace
Royalty reports
Strategy reports
Therapy-based reports
Technology type reports
Geographic reports
Company reports
Other
Services
Current Agreements
Deal Tracker
Therapy Tracker
Technology Tracker
Deals on Demand
Dealmaker’s Knowledge Centre
Insight
Articles
Points of view
Glossary
Top 50 Pharma
News
Partnering
M&A
Financing
Dealtalk
Events
Featured events
Partnering
Conferences
Training
Exhibitions
Scorecard
Partnering scorecard
M&A scorecard
Financing scorecard
Bigpharma dealmaking
R&D spending
Deal metrics
About Us
The people
Press releases
In the media
Sponsors
Advertising options
License type definitions
Terms & conditions / privacy
Contact Us
Enquiry
Subscribe
Subscribe via:
RSS
Other
Blog in Blog:
There are no posts that match the selection criteria.
Latest News
Popular
Latest Comments
Cephalon: Company Profile
Warner Chilcott: Company Profile
Alcon: Company Profile
Shire: Company Profile
Biogen Idec: Company Profile
Top twenty partnering deals of 2011 have a combined value of over $21 billion
Vical and Teva Pharmaceutical establish sales and marketing agreement for Allovectin-7(r) in Israel
Biopharma partnering: Perspectives from BCG’s latest biotech and pharma partnering study
Biotech investing at a crossroads?
Medtronic sells defibrillator unit to Bain Capital for $487 million
tom squitt: Watson and Amgen are trying to take over the Biote...
Claire Nicholson: Hello Pamela, thanks for your message! If you clic...
Steve Poile: Thanks for your comment. Of course, I agree with...
David Scott: Nice summary Steve. Notwishstanding that the headl...
Pamela Agner: Please send an e-copy of Biopharma partnering: Per...
Latest Tweets
Error: Twitter did not respond. Please wait a few minutes and refresh this page.
Tags
Abbott
Actavis
Alcon
Allergan
Amgen
asset purchase
Astellas
AstraZeneca
Baxter
Bayer
best practice
Biogen Idec
biomarkers
biosimilars
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Cephalon
china
Chugai
co-development
co-marketing
co-promotion
collaborative R&D
companion diagnostic
CSL
Current Agreements
Daiichi Sankyo
Dainippon Sumitomo
Dealdoc
dealtalk
dermatology
diabetes
diagnostic
drug delivery
drug discovery
Eisai
Eli Lilly
emerging markets
financings
finding partners
Forest
Genentech
generics
Genzyme
Gilead
Gilead Sciences
GlaxoSmithKline
Hospira
innovation
IP
J&J
Janssen
joint venture
Kyowa Hakko Kirin
licensing
Lundbeck
M&A
manufacturing
Marketplace
medical device
Merck
Merck KGaA
Mitsubishi
Mitsubishi Tanabe
Mylan
non-profit
Novartis
Novo Nordisk
Nycomed
oncology
option
Otsuka
partnering
partnering agreements
partnering terms
patents
personalized medicine
Pfizer
phase III
report
Roche
royalty financing
royalty rates
Sanofi
Servier
shire
specialty pharma
strategy
supply
Takeda
terminations
Teva
UCB
vaccines
valuation
venture capital
Warner Chilcott
Watson